Palombella Vito J.
Insider CIK 1492805 · INFI Chief Scientific Officer · SURF Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SURF Surface Oncology, Inc. | D To issuer deriv | 2023-09-08 | 2023-09-08 | 150,000 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | D To issuer | 2023-09-08 | 2023-09-08 | 87,212 | — | $0 | 0 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2022-08-03 | 2022-08-05 | 4,463 | $1.72 | $7.7K | 87,212 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 108,000 | — | $0 | 108,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award | 2022-03-01 | 2022-03-03 | 38,000 | — | $0 | 91,675 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2021-07-21 | 2022-01-14 | 26,325 | $6.10 | $160.6K | 53,675 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 82,000 | — | $0 | 82,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SURF Surface Oncology, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2015-06-15 | 2015-06-16 | 4,737 | $10.97 | $52.0K | 868 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2015-04-30 | 2015-05-01 | 4,737 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2015-04-30 | 2015-05-01 | 4,737 | $2.04 | $9.7K | 5,605 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2015-01-14 | 2015-01-16 | 85,000 | — | $0 | 85,000 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-12-15 | 2014-12-16 | 4,737 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-12-15 | 2014-12-16 | 4,737 | $16.32 | $77.3K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-12-15 | 2014-12-16 | 4,737 | $2.04 | $9.7K | 4,737 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-11-26 | 2014-11-28 | 4,736 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-11-26 | 2014-11-28 | 4,736 | $2.04 | $9.7K | 4,736 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-11-26 | 2014-11-28 | 4,736 | $15.00 | $71.0K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-09-03 | 2014-09-05 | 7,105 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-09-03 | 2014-09-05 | 2,367 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-09-03 | 2014-09-05 | 9,472 | $15.39 | $145.8K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-09-03 | 2014-09-05 | 7,105 | $2.04 | $14.5K | 7,105 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-09-03 | 2014-09-05 | 2,367 | $2.04 | $4.8K | 9,472 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-07-01 | 2014-07-02 | 879 | $12.87 | $11.3K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2014-06-30 | 2014-07-02 | 879 | $10.83 | $9.5K | 879 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2014-02-25 | 2014-02-27 | 4,736 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2014-02-25 | 2014-02-27 | 4,736 | $2.04 | $9.7K | 4,736 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-02-25 | 2014-02-27 | 4,736 | $15.00 | $71.0K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2014-01-10 | 2014-01-14 | 32,200 | — | $0 | 32,200 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2014-01-02 | 2014-01-06 | 753 | $13.52 | $10.2K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award | 2013-12-31 | 2014-01-06 | 753 | $11.74 | $8.8K | 753 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2013-09-27 | 2013-09-30 | 4,736 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2013-09-27 | 2013-09-30 | 4,736 | $2.04 | $9.7K | 4,736 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-09-27 | 2013-09-30 | 4,736 | $17.28 | $81.8K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise deriv | 2013-06-20 | 2013-06-21 | 22,103 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | M Exercise | 2013-06-20 | 2013-06-21 | 22,103 | $1.72 | $38.0K | 23,150 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | S Sale | 2013-06-20 | 2013-06-21 | 23,150 | $18.53 | $429.0K | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2013-01-04 | 2013-01-08 | 65,600 | — | $0 | 65,600 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2012-01-06 | 2012-01-09 | 47,136 | — | $0 | 47,136 | SEC↗ |